Security
TWGL · AIBOTICS, INC.
TWGLNYSE_AMERICANCommon stockHistorical · closed May 3, 2021CIK 1763329Updated Sep 27, 2026
Name history
Mycotopia Therapies, Inc. · through Dec 17, 202420/20 Global, Inc. · through May 19, 2021
Current security for this SEC filerAIBT · OTC
TWGL price & chart
Historical security
This listing closed May 3, 2021. Live provider charts are shown only for current listings.
Current security: AIBT
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 874,673Source | 1,456,995Source | 2,219,413Source | 387,395Source |
| Property, Plant and Equipment, NetUSD | — | 0Source | 498Source | 1,496Source |
| Current assets: | ||||
| Assets, CurrentUSD | 270,107Source | 185,097Source | 279,134Source | 385,899Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 4,834,905Source | 4,851,763Source | 4,247,723Source | 1,278,743Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 486,895Source | 39,991Source | 14,897Source | 14,857Source |
| Additional Paid in CapitalUSD | 8,577,680Source | 7,374,297Source | 6,917,774Source | 6,873,429Source |
| Retained Earnings (Accumulated Deficit)USD | -13,025,007Source | -10,809,256Source | -8,960,981Source | -7,779,634Source |
| Stockholders' Equity Attributable to ParentUSD | -3,960,232Source | -3,394,768Source | -2,028,310Source | -891,348Source |
| Liabilities and EquityUSD | 874,673Source | 1,456,995Source | 2,219,413Source | 387,395Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 4,793,865Source | 4,851,763Source | 4,247,723Source | 764,513Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 216,734Source | 399,822Source | 239,714Source | 0Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | 0Source | 635Source | 1,022,855Source |
| Deferred Income Tax Expense (Benefit)USD | — | 0Source | 0Source | 0Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -458,240Source | -259,037Source | -106,765Source | -656,620Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | 0Source | 0Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | 0Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 529,083Source | 165,000Source | 0Source | -225,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | -881,620Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 255,940Source | 185,097Source | 279,134Source | 385,899Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 0Source | — | — | — |
| Additional Financial Items | ||||
| AmortizationUSD | 667,332Source | 667,883Source | 60,219Source | — |
| Amortization of Debt Issuance Costs and DiscountsUSD | — | — | — | 764,028Source |
| DepreciationUSD | 0Source | 498Source | 998Source | 1,001Source |
| General and Administrative ExpenseUSD | 1,846,856Source | 1,634,817Source | 616,724Source | 1,736,336Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -2,215,751Source | -1,848,275Source | -1,181,347Source | -2,611,869Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -0.01Source | — | — | — |
| Nonoperating Income (Expense)USD | -371,078Source | -213,458Source | -564,623Source | -875,533Source |
| Operating ExpensesUSD | 1,846,856Source | 1,634,817Source | 616,724Source | 1,736,336Source |
| Proceeds from Issuance of Common StockUSD | 279,083Source | — | — | — |
| Proceeds from Issuance of Redeemable Preferred StockUSD | — | — | 0Source | 150,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 2,183Source | — | — | — |
| Operating Income (Loss)USD | -1,844,673Source | -1,634,817Source | -616,724Source | -1,736,336Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -2,215,751Source | -1,848,275Source | -1,181,347Source | -2,611,869Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -2,215,751Source | -1,848,275Source | -1,181,347Source | -2,611,869Source |
| Additional Financial Items | ||||
| Current Income Tax Expense (Benefit)USD | — | 0Source | 0Source | 0Source |
| General and Administrative ExpenseUSD | 1,846,856Source | 1,634,817Source | 616,724Source | 1,736,336Source |
| Gross ProfitUSD | 2,183Source | — | — | — |
| Interest ExpenseUSD | 226,902Source | 213,458Source | 564,623Source | 868,330Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -0.01Source | — | — | — |
| Nonoperating Income (Expense)USD | -371,078Source | -213,458Source | -564,623Source | -875,533Source |
| Operating ExpensesUSD | 1,846,856Source | 1,634,817Source | 616,724Source | 1,736,336Source |